Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 30, 2020

View Archived Issues

Buyer beware for SARS-CoV-2 antibody detection

Breathing new life into obsolete antibiotics

Sorrento reports preclinical data on COVI-GUARD and COVI-AMG for COVID-19

Heparan sulfate acts as a coreceptor of SARS-CoV-2, priming the spike protein for ACE2 interaction

Bifunctional hybrid nanoscaffold for SCI: anti-inflammation and biomimetic neural matrix formation

Interim data from phase I/IIa study of Janssen's COVID-19 vaccine candidate

Moleculin discovers new antimetabolites with significant in vitro activity against COVID-19

FDA accepts IND application for lucinactant in COVID-19-associated acute lung injury

Positive topline phase I data for ROSgard in patients with renal impairment

Lipid metabolism controls lung cancer metastasis, not just diseases like atherosclerosis

Biogen identifies new N-acetyl-beta-D-glucosaminidase inhibitors

Janssen presents anti-hepatitis B virus compounds

ER Stress Research Institute patents eIF-2-alpha inhibitors

Universidade Nova de Lisboa and collaborators describe new free radical scavengers/antioxidants

Pembrolizumab in first-line esophageal cancer: first data from KEYNOTE-590

New IL-7 modulators discovered at Leo Pharma

AK-104 demonstrates safety and antitumor activity in patients with mesothelioma

Sarepta reports data from ongoing first-in-human study of SRP-9003 for LGMD2E

Oncternal Therapeutics presents phase I data for TK-216

REG-1-alpha identified as a marker of gestational diabetes

FDA approves Xeljanz for active polyarticular course juvenile idiopathic arthritis

Ironwood to discontinue IW-3718 for GERD

Zucara initiates phase I study of ZT-01 to prevent insulin-induced hypoglycemia in type 1 diabetes

FDA accepts IND for phase IIb study of AR-15512 in dry eye disease

New phase III trial to evaluate bucillamine in COVID-19

Arcutis reports topline phase II data on roflumilast topical foam for seborrheic dermatitis

Regeneron reports data on REGN-COV2 in nonhospitalized patients with COVID-19

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...